Uppsala, den 1 september 2025 – Orexo AB (publ) (STO:ORX) (OTCQX:ORXOY) kommer i samarbete med sina juridiska rådgivare, Potter Clarkson LLP och Steptoe LLP, arrangera ett seminarium om utformningen av robusta patentstrategier för att skydda immateriella rättigheter inom läkemedelsindustrin, även vid fientlig generisk opposition. Seminariet riktar sig till innovatörer, läkemedels- och bio...

Uppsala, Sweden – August 29, 2025 – Orexo (publ.), (STO:ORX) (OTCQX:ORXOY) in collaboration with its advisory international law firms Potter Clarkson LLP and Steptoe LLP, will host a seminar on how to build robust patent strategies that will protect pharmaceutical IP even in the face of hostile generic opposition. The session, targeting innovators, pharma companies, biotech firms and investors...

Formulating therapeutics as powders offers significant advantages over liquids, particularly for stabilizing fragile compounds that degrade under varying environmental conditions. This approach enhances molecular stability, extends shelf life, and eliminates the need for cold chain logistics. Orexo has emerged as a leader in the intranasal delivery of powder-based medications thanks to its proprie...

Anneli’s role spans everything from early stage concepting to interrogating solutions, blending chemistry with creative thinking and leadership with coaching. In this interview, Anneli reveals more about the variety in her role, digging into data and what she’s looking forward to in the year ahead. What does your role as a senior analytical chemist involve? It’s incredibly varied – I’m i...